ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.37
-0.26 (-3.92%)
At close: Mar 13, 2026, 4:00 PM EDT
6.49
+0.12 (1.88%)
After-hours: Mar 13, 2026, 4:04 PM EDT

ImmuCell Revenue

In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth. ImmuCell had revenue of $7.63M in the quarter ending December 31, 2025, a decrease of -1.61%.

Revenue (ttm)
$27.64M
Revenue Growth
+4.34%
P/S Ratio
2.08
Revenue / Employee
$329,095
Employees
84
Market Cap
57.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.64%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.01K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 202015.34M1.62M11.80%
Dec 31, 201913.72M2.74M24.91%
Dec 31, 201810.99M555.21K5.32%
Dec 31, 201710.43M887.13K9.30%
Dec 31, 20169.54M-684.73K-6.69%
Dec 31, 201510.23M2.63M34.64%
Dec 31, 20147.60M1.59M26.46%
Dec 31, 20136.01M617.24K11.45%
Dec 31, 20125.39M278.79K5.45%
Dec 31, 20115.11M724.95K16.53%
Dec 31, 20104.39M-119.56K-2.65%
Dec 31, 20094.51M-122.55K-2.65%
Dec 31, 20084.63M-6.21M-57.31%
Dec 31, 200710.84M1.73M19.04%
Dec 31, 20069.11M-109.26K-1.19%
Dec 31, 20059.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition